/Investor DB

BlueYard Capital — 2021 Investments

4 investments dated 2021 · listed companies and verified rows first · show all

Astranisastranis.comin𝕏Apr 2021

Astranis manufactures small, high-powered geosynchronous satellites equipped with advanced digital processing technology for global telecommunications and connectivity services.

Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US

John Gedmark(CEO)inRyan McLinko(CTO)inMike Mancini(Executive Officer)Siamak Ebadi(Lead RF Engineer)inHall Chen(RF Payload Design)inShraddha Pandya(Talent Acquisition)

Co-investorsAndreessen HorowitzATEL VenturesBlack FlagBoxGroupCantos VenturesCherubic Ventures+87 more

Insemprainsempra.bioin𝕏Seed · May 2021 · $15M

Insempra develops biological manufacturing processes that replace petrochemical-dependent production methods, enabling businesses to produce naturally superior products at scale.

Advanced ManufacturingBiotechCleantechClimate TechNew Materials

Jens Klein(CEO)Lin Römer(COO)

Co-investorsAcequia Capital (AceCap)Alante CapitalBayern KapitalEQT Ventures

Lottielottie.org𝕏Seed · Feb 2021

Lottie operates a UK directory and search platform that helps families find later-life care, listing regulated care homes and home care services with availability and pricing information.

ConsumerHealthtechMarketplaces

Will Donnelly(Founder)inChris Donnelly(Founder)Chris Donnelly Will Donnelly(Founder)

Co-investorsAccelGeneral CatalystKindred CapitalAccel-KKRCreator VenturesPraetura Ventures

Zafrenszafrens.cominSeries A · Dec 2021 · $23M

Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.

AI & Machine LearningBiotechDeep TechSan Diego, US

Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin

BoardJustin Briggsin

Co-investorsAcequia Capital (AceCap)FoundersX VenturesGlobal BrainHAWKTAILIaso Venturesimec.xpand+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.